Primary Cardiac Tumors: Clinical Presentations and Pathological Features in a Multicenter Cohort
Authors:
- Esra Çobankent AytekinEsra Çobankent Aytekin
- Kemal BehzatoğluKBKemal Behzatoğlu
- Arzu AkçayAAArzu Akçay
- Ayşe Özgün ŞahinAŞAyşe Özgün Şahin
- Naile KökbudakNaile Kökbudak
- Fahriye KılınçFKFahriye Kılınç
- Aylin Okçu HeperAHAylin Okçu Heper
- Olcay KurtulanOKOlcay Kurtulan
- Gülay ÖzbilimGÖGülay Özbilim
- Reyhan EğilmezREReyhan Eğilmez
- Tülay KoçTKTülay Koç
- Doğuş Özdemir KaraDKDoğuş Özdemir Kara
Open Access
- 4 August 2025
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 15 (15) , 1951
Abstract
Background: Cardiac tumors are rare neoplasms with a wide spectrum of clinical presentations, ranging from asymptomatic cases to fatal outcomes. According to the 2021 thoracic tumor classification of the World Health Organization (WHO), papillary fibroelastoma (PFE) is the most common primary cardiac tumor. This study aimed to aggregate and examine data regarding the prevalence, clinical characteristics, and histological results of cardiac tumors. Methods: This multicenter retrospective study was conducted across seven tertiary care institutions and included 274 patients diagnosed with histopathologically confirmed cardiac tumors between January 2013 and December 2024. Results: This study included 274 patients, with an average age of 52.6 ± 16.6 years. Of the study participants, 120 (43.8%) were male and 154 (56.2%) were female. The most prevalent clinical manifestations were dyspnea (43.7%), thoracic pain (22.5%), and cardiac palpitations (21.1%). Echocardiography was the principal diagnostic method, revealing an average tumor size of 3 cm. The most commonly observed mass was cardiac myxoma (CM) in 192 patients (70.1%). The second most frequently detected mass was PFE (28 cases, 10.2%). The third most common cardiac mass was a metastatic tumor (6.9%). Surgical resection was performed in all patients, with infection being the most prevalent consequence, followed by effusion. Conclusions: Cardiac tumors, albeit uncommon, provide considerable diagnostic and treatment difficulties. Our research is founded on an extensive case series that has been histopathologically validated and sourced from various national tertiary centers. This comprehensive dataset offers epidemiological and clinical insights regarding heart tumors in Turkey. Another key finding of our study is that, even though the 5th edition of the 2021 WHO Classification of Thoracic Tumors lists PFE as the most common primary cardiac tumor, myxoma is actually the most common primary cardiac tumor in our study and in many other studies. This finding demonstrates a significant discrepancy between the current international classification and real-world data and suggests that tumor distribution may be related to regional and demographic differences.Keywords
This publication has 24 references indexed in Scilit:
- The 2021 WHO Classification of Tumors of the HeartJournal of Thoracic Oncology, 2022
- Cardiac tumors prevalence and mortality: A systematic review and meta-analysisInternational Journal of Surgery, 2020
- Cardiac Tumors: Clinical Presentation, Diagnosis, and ManagementCurrent Treatment Options in Oncology, 2019
- High Prevalence of Subclinical Infarction in Asymptomatic Patients With Silent Left-Sided Cardiac MassesJACC, 2019
- A 20-Year Experience With Resection of Primary Cardiac Tumors and Metastatic Tumors of the HeartThe Annals of Thoracic Surgery, 2019
- Cardiac papillary fibroelastoma: Report of a surgical seriesRevista Portuguesa de Cardiologia, 2018
- Cardiac massesHerz, 2016
- Prognostic and Bioepidemiologic Implications of Papillary FibroelastomasJACC, 2015
- Cardiac tumours: diagnosis and managementThe Lancet Oncology, 2005
- Cardiac Myxoma:A Clinicopathologic StudyAmerican Journal of Clinical Pathology, 1993